Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLIT3 antisense RNA 1 (SLIT3-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the SLIT3 locus[4]. As a non-coding RNA, SLIT3-AS1 does not encode a protein and is distinct from the SLIT3 protein, which is a well-studied axon guidance and angiogenic factor. While there is extensive literature on the coding gene SLIT3 and its roles in neural guidance, angiogenesis, and tumor suppression, there is currently no functional characterization, disease association, or therapeutic targeting described for SLIT3-AS1 in the provided literature[4]. Its biological roles, disease relevance, and utility as a therapeutic or biomarker target remain uncharacterized in the present scientific record.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLIT3 antisense RNA 1 (SLIT3-AS1).